We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+35.45%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$546M
AUM Growth
+$198M
Cap. Flow
+$75.2M
Cap. Flow %
13.79%
Top 10 Hldgs %
72.11%
Holding
178
New
146
Increased
5
Reduced
9
Closed
18

Top Buys

Rank Stock Value
1
PCG icon
PG&E
PCG
+$12.6M
2
AVGO icon
Broadcom
AVGO
+$4.76M
3
BRX icon
Brixmor Property Group
BRX
+$4.65M
4
HIW icon
Highwoods Properties
HIW
+$4.39M
5
WOR icon
Worthington Enterprises
WOR
+$4.09M

Top Sells

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$45.2M
2
KRC icon
Kilroy Realty
KRC
+$7M
3
MU icon
Micron Technology
MU
+$6.18M
4
BXP icon
Boston Properties
BXP
+$4.09M
5
KLAC icon
KLA
KLAC
+$3.83M

Sector Composition

Rank Sector Weight
1 Healthcare 61.2%
2 Technology 7.31%
3 Real Estate 4.22%
4 Utilities 1.88%
5 Materials 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPO icon
176
XPO
XPO
$23.6B
-36,142
Closed -$609K
CMBT
177
CMB.TECH NV
CMBT
$4.69B
-80,000
Closed -$902K
RPAI
178
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
-100,000
Closed -$517K

Similar funds

Crestline Management's Q2 2020 Portfolio in Review

As of Q2 2020, Crestline Management held 178 positions worth $546M, up 57% from $347M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Crestline Management deployed $75.2M of net new capital in Q2 2020, opening 146 new positions and adding to 5 existing holdings. Its largest new stake was PG&E: 1,155,000 shares worth $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, down from 78% a quarter earlier, followed by Technology and Real Estate.

On the sell side, the largest reduction was Denali Therapeutics, an estimated $45.2M trimmed.

  • Crestline Management's largest Q2 2020 buy was PG&E: 1,155,000 shares worth $10.2M.
  • Crestline Management added most to NXP Semiconductors in Q2 2020, an estimated $1.58M increase.
  • Crestline Management's biggest Q2 2020 reduction was Denali Therapeutics, cutting an estimated $45.2M.
  • Crestline Management fully exited Kilroy Realty in Q2 2020, selling an estimated $7M.
  • Crestline Management's ten largest holdings make up 72% of its $546M portfolio in Q2 2020.
  • Crestline Management opened 146 new positions and closed 18 in Q2 2020.
  • Crestline Management's portfolio value rose 57% quarter-over-quarter to $546M.

Based on Crestline Management's 13F filing for Q2 2020, filed 14 Aug 2020.